NOS3 and diabetic kidney disease: In a streptozotocin (STZ) model of type I diabetes in mice, wild type mice developed mesangial expansion and moderate albuminuria after 24 weeks of diabetes, and mice with selective deletion of endothelial nitric oxide synthase (eNOS–/–) had markedly exacerbated development of diabetic nephropathy [16].